Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02730481 |
Title | A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Athenex, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
Cancer Therapy &Research Center @ UTHSCSA | San Antonio | Texas | 78229 | United States | Details |